<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Emer T. Chang | Dr Aman Josan</title>
    <link>/author/emer-t.-chang/</link>
      <atom:link href="/author/emer-t.-chang/index.xml" rel="self" type="application/rss+xml" />
    <description>Emer T. Chang</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Wed, 13 Jul 2022 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>Emer T. Chang</title>
      <link>/author/emer-t.-chang/</link>
    </image>
    
    <item>
      <title>A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept and Laser for Retinopathy of Prematurity</title>
      <link>/publication/featured-article/chang-a-network-meta-analysis-of-retreatment-in-rop/</link>
      <pubDate>Wed, 13 Jul 2022 00:00:00 +0000</pubDate>
      <guid>/publication/featured-article/chang-a-network-meta-analysis-of-retreatment-in-rop/</guid>
      <description>&lt;p&gt;
  &lt;i class=&#34;fas fa-download  pr-1 fa-fw&#34;&gt;&lt;/i&gt; Download article &lt;a href=&#34;/files/1-s2.0-S016164202200522X-main.pdf&#34; target=&#34;_blank&#34;&gt;PDF&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;
  &lt;i class=&#34;fas fa-download  pr-1 fa-fw&#34;&gt;&lt;/i&gt; &lt;strong&gt;Full R code for network meta-analysis&lt;/strong&gt; &amp;mdash;&amp;ndash;&amp;gt;  &lt;a href=&#34;https://github.com/amanasj/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;github page&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;
  &lt;i class=&#34;fas fa-external-link-alt  pr-1 fa-fw&#34;&gt;&lt;/i&gt; Publisher page: &lt;a href=&#34;https://doi.org/10.1016/j.ophtha.2022.06.042&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;DOI&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
